Multimodal AI model outperforms established biomarkers for immunotherapy in lung cancer
A large international real-world study found that a multimodal explainable AI decision support tool outperformed established biomarkers for predicting immunotherapy outcomes in non-small cell lung cancer and improved physician decision-making.